Correction: Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions
Saved in:
| Main Authors: | Cristina Visentin, Giulia Rizzi, Wen Yin, Mathilde Hotot, Dipambita Roy, Torbjörn Gräslund, Riccardo Capelli, Stefano Ricagno |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Biology Direct |
| Online Access: | https://doi.org/10.1186/s13062-025-00679-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions
by: Cristina Visentin, et al.
Published: (2025-06-01) -
Platelet aggregation study: Valuable aid to diagnose dysfibrinogenemia.
by: Abhishek Purohit, et al.
Published: (2014-08-01) -
Covalent Affibody‐Molecular Glue Drug Conjugate Nanoagent for Proximity‐Enabled Reactive Therapeutics
by: Wenhui Gao, et al.
Published: (2025-03-01) -
Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.
by: Shanli Zhu, et al.
Published: (2020-01-01) -
DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells
by: Pierre Cheung, et al.
Published: (2025-01-01)